Shlomo Yanai Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

Shlomo Yanai is Director of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 285,985 shares of AMRX, which is worth approximately $2.41 Million. The most recent transaction as insider was on May 05, 2025, when has been sold 40,258 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 286K

16.38% 3M change

16.38% 12M change

Total Value Held $2.41 Million

Shlomo Yanai Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 05 2025	BUY Exercise of conversion of derivative security	-	40,258 Added 12.34%	285,985 Class A Common Stock
May 10 2024	BUY Exercise of conversion of derivative security	-	76,453 Added 23.73%	245,727 Class A Common Stock
May 10 2023	BUY Exercise of conversion of derivative security	-	80,128 Added 32.13%	169,274 Class A Common Stock
May 08 2022	BUY Exercise of conversion of derivative security	-	35,406 Added 28.43%	89,146 Class A Common Stock
May 06 2021	BUY Exercise of conversion of derivative security	-	46,218 Added 46.24%	53,740 Class A Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	-	7,522 Added 50.0%	7,522 Class A Common Stock

Also insider at

Philip Morris International Inc. Consumer Defensive

Director

Shlomo Yanai

Director

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Value

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX

Account